Hepatocellular Carcinoma

Researchers' work from the People's Republic of China, Taiwan and Netherlands adds to hepatocellular carcinoma body of knowledge

Published in Hepatitis Weekly, August 21st, 2006

Hepatocellular carcinoma data are the focus of recent research from the People's Republic of China, Taiwan and Netherlands.

Study 1: According to recent research from the People's Republic of China, estrogen receptor (ER) alpha polymorphisms are associated with susceptibility to hepatocellular carcinoma (HCC) in hepatitis B virus carriers.

"Overexpression of ESRs is implicated in the development of HCC in both animal models and humans. We examined whether the ESR1 polymorphisms were related to HCC risk among chronic hepatitis B virus carriers," wrote Y. Zhai and colleagues, Beijing Institute of Radiation Medicine.

"Six ESR1...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2006-08-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry